MSD Pharma Gets CDSCO Panel Nod for additional indication of anticancer drug Pembrolizumab Dr. Divya Colin23 May 2023 12:30 PM GMTNew Delhi: Based on the global clinical trial data presented by drug major, MSD Pharmaceuticals, the Subject Expert Committee (SEC) functional under...
Emcure, MSD get CDSCO Panel conditional nod to Manufacture, Market HIV drug Doravirine Dr. Divya Colin26 March 2023 12:30 PM GMTNew Delhi: Citing the unmet need, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has...
MSD Pharma likely to participate in global tender for procurement of HPV vaccine against cervical cancer Ruchika Sharma16 Feb 2023 5:58 AM GMTThe Union Health Ministry is likely to float a global tender for HPV in April for 16.02 crore doses to be procured by 2026.
Biophore India gets MPP licence to market molnupiravir Dr. Divya Colin22 Jan 2022 9:44 AM GMTNew Delhi: Biophore India Pharmaceuticals on Thursday said it has received licences from Medicines Patent Pool (MPP) on behalf of originator company...
MSD Pharma launches gender-neutral HPV vaccine GARDASIL 9 in India Ruchika Sharma30 Sep 2021 9:14 AM GMTNew Delhi: MSD Pharmaceuticals on Wednesday said it has launched first gender-neutral HPV vaccine, GARDASIL 9, in the country.The 9-valent Human...
